Intracellular cytokine production by dengue virus-specific T cells correlates with subclinical secondary infection

Journal of Infectious Diseases

Volumn 203, Issue 9, 2011, Pages 1282-1291

  Hatch, Steven ^a   Endy, Tim P ^b   Thomas, Stephen ^c   Mathew, Anuja ^a   Potts, James ^a   Pazoles, Pamela ^a   Libraty, Daniel H ^a   Gibbons, Robert ^b   Rothman, Alan L ^a  

^a UNIVERSITY OF MASSACHUSETTS   (United States)

^b STATE UNIVERSITY OF NEW YORK   (United States)

^c Army Medical Department Center and School   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON; INTERLEUKIN 2; TUMOR NECROSIS FACTOR ALPHA; VIRUS ANTIGEN;

ARTICLE; CASE CONTROL STUDY; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DENGUE; DENGUE VIRUS; DISEASE SEVERITY; HUMAN; IMMUNE RESPONSE; LYMPHOCYTE ACTIVATION; NONHUMAN; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SCHOOL CHILD; SECONDARY INFECTION;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CYTOKINES; DENGUE; DENGUE VIRUS; HUMANS; T-LYMPHOCYTES;

EID: 79954588278     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/jir012     Document Type: Article

References (28)

1. Kroeger A, Nathan M, Hombach J. Dengue. Nat Rev Microbiol 2004;2:360-1. (Pubitemid 39490115)
2. Dengue fever climbs the social ladder. Nature 2007;448:734-5.
3. Sabin AB. Research on dengue during World War II. Am J Trop Med Hyg 1952;1:30-50.
4. Okuno Y, Fukunaga T, Srisupaluck S, Kasemsarn P, Dharakul C, Sangkawibha N. Serological and virological studies on patients with dengue hemorrhagic fever (DHF) in Chanthaburi province, Thailand. I. Serological studies on paired sera from DHF patients by neutralization (N), hemagglutination inhibition (HI) and staining tests. Biken J 1980;23:113-21. (Pubitemid 11220407)
5. Sangkawibha N, Rojanasuphot S, Ahandrik S, et al. Risk factors in dengue shock syndrome: a prospective epidemiologic study in Rayong, Thailand. I. The 1980 outbreak. Am J Epidemiol 1984;120:653-69. (Pubitemid 15210730)
6. Graham RR, Juffrie M, Tan R, et al. A prospective seroepidemiologic study on dengue in children four to nine years of age in Yogyakarta, Indonesia I. studies in 1995-1996. Am J Trop Med Hyg 1999;61:412-9. (Pubitemid 29428712)
7. Guzman MG, Kouri G. Dengue and dengue hemorrhagic fever in the Americas: lessons and challenges. J Clin Virol 2003;27:1-13. (Pubitemid 36513584)
8. Kliks SC, Nisalak A, Brandt WE, Wahl L, Burke DS. Antibodydependent enhancement of dengue virus growth in human monocytes as a risk factor for dengue hemorrhagic fever. Am J Trop Med Hyg 1989;40:444-51. (Pubitemid 19117544)
9. Kurane I, Rothman AL, Livingston PG, et al. Immunopathologic mechanisms of dengue hemorrhagic fever and dengue shock syndrome. Arch Virol Suppl 1994;9:59-64.
10. Rothman AL, Ennis FA. Immunopathogenesis of Dengue hemorrhagic fever. Virology 1999;257:1-6. (Pubitemid 29391794)
11. Endy TP, Chunsuttiwat S, Nisalak A, et al. Epidemiology of inapparent and symptomatic acute dengue virus infection: a prospective study of primary school children in Kamphaeng Phet, Thailand. Am J Epidemiol 2002;156:40-51. (Pubitemid 34680622)
12. Lanciotti RS, Calisher CH, Gubler DJ, Chang GJ, Vorndam AV. Rapid detection and typing of dengue viruses from clinical samples by using reverse transcriptase-polymerase chain reaction. J Clin Microbiol 1992;30:545-51.
13. Vaughn DW, Green S, Kalayanarooj S, et al. Dengue in the early febrile phase: viremia and antibody responses. J Infect Dis 1997;176:322-30. (Pubitemid 27328753)
14. Innis BL. Antibody responses to dengue virus infection. In Gubler DJ, Kuno G, eds: Dengue and dengue hemorrhagic fever. New York: CAB International, 1997;221-43.
15. Dengue: Guidelines for Diagnosis, Treatment, Prevention Control. World Health Organization, 2009.
16. Mangada MM, Ennis FA, Rothman AL. Quantitation of dengue virus specific CD4+ T cells by intracellular cytokine staining. J Immunol Methods 2004;284:89-97. (Pubitemid 38084916)
17. Mangada MM, Endy TP, Nisalak A, et al. Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren. J Infect Dis 2002;185:1697-703. (Pubitemid 34615461)
18. Mangada MM, Rothman AL. Altered cytokine responses of denguespecific CD4+ T cells to heterologous serotypes. J Immunol 2005;175:2676-83. (Pubitemid 41113883)
19. Bashyam HS, Green S, Rothman AL. Dengue virus-reactive CD8+ T cells display quantitative and qualitative differences in their response to variant epitopes of heterologous viral serotypes. J Immunol 2006;176:2817-24.
20. Imrie A, Meeks J, Gurary A, et al. Differential functional avidity of dengue virus-specific T-cell clones for variant peptides representing heterologous and previously encountered serotypes. J Virol 2007;81:10081-91. (Pubitemid 350067712)
21. Stephens HA, Klaythong R, Sirikong M, et al. HLA-A and-B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais. Issue Antigens 2002;60:309-18. (Pubitemid 36020803)
22. Rico-Hesse R. Microevolution and virulence of dengue viruses. Adv Virus Res 2003;59:315-41. (Pubitemid 137639369)
23. Nascimento EJ, Silva AM, Cordeiro MT, et al. Alternative complement pathway deregulation is correlated with dengue severity. PLoS One 2009;4:e6782.
24. Endy TP, Nisalak A, Chunsuttitwat S, et al. Relationship of preexisting dengue virus (DV) neutralizing antibody levels to viremia and severity of disease in a prospective cohort study of DV infection in Thailand. J Infect Dis 2004;189:990-1000. (Pubitemid 38373090)
25. Bozza FA, Cruz OG, Zagne SM, et al. Multiplex cytokine profile from dengue patients: MIP-1beta and IFN-gamma as predictive factors for severity. BMC Infect Dis 2008;8:86.
26. Mustafa AS, Elbishbishi EA, Agarwal R, Chaturvedi UC. Elevated levels of interleukin-13 and IL-18 in patients with dengue hemorrhagic fever. FEMS Immunol Med Microbiol 2001;30:229-33. (Pubitemid 32373298)
27. Guy B, Nougarede N, Begue S, et al. Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects. Vaccine 2008;26:5712-21.
28. Hatch S, Mathew A, Rothman A. Dengue vaccine: opportunities and challenges. IDrugs 2008;11:42-5.